Article
Familial Alzheimer's Disease and Recessive Modifiers.
Molecular neurobiology - 1 Feb 2020
Vélez Jorge I, Lopera Francisco, Silva Claudia T, Villegas Andrés, Espinosa Lady G, Vidal Oscar M, Mastronardi Claudio A, Arcos-Burgos Mauricio
Abstract excerpt
Alzheimer's disease (AD) is progressive brain disorder that affects ~ 50 million people worldwide and has no current effective treatment. AD age of onset (ADAOO) has shown to be critical for the identification of genes that modify the appearance of AD signs and symptoms in a specific population. We clinically characterized and whole-exome genotyped 71 individuals with AD from the Paisa genetic isolate,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
